Literature DB >> 6088011

Effects of vitamin D and parathyroid hormone on cyclic AMP production by bone cells isolated from rat calvariae.

J A Crowell, C W Cooper, S U Toverud, A Boass.   

Abstract

Studies presented here were designed to investigate further the basis for an impaired cAMP response to parathyroid hormone (PTH) in osteoblastlike calvarial bone cells isolated from vitamin D-deficient rat pups. The goal was to perturb Ca, PTH, and vitamin D in vivo in order to see which factors might be responsible for the impaired in vitro bone cell cAMP response. Pups either were parathyroidectomized (PTX) 3-5 days, implanted with osmotic minipumps delivering high doses of PTH, given repeated, high doses of 1,25(OH)2D3, or were D-deficient (-D, i.e., born and suckled by D-deficient mothers). Osteoblastlike bone cells, isolated by sequential enzyme digestion and centrifugation, were exposed to PTH for 5 min in the presence of a phosphodiesterase inhibitor. In bone cells isolated from -D rat pups, both basal and PTH-induced cAMP accumulation were significantly lower than in +D bone cells. Earlier, we had shown that two daily injections of -D pups with 50 ng 1,25(OH)2D3 restores this reduced bone cAMP response of -D pups toward normal. In the present study, neither basal nor PTH-induced bone cell cAMP accumulation was affected by subjecting D-replete pups to PTX, PTH infusion, or repeated high doses of 1,25(OH)2D3 despite the fact that each treatment markedly changed serum Ca or serum immunoreactive PTH. The results indicate that the impaired bone cell cAMP response seen in -D pups is not a direct result of chronic hypocalcemia and that the "heterologous desensitization" seen in vitro with added 1,25(OH)2D3 could not be duplicated by in vivo treatment of +D pups with supraphysiologic doses of 1,25(OH)2D3.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088011     DOI: 10.1007/bf02405337

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  32 in total

1.  Hormone-specific suppression of adenosine 3',5'-monophosphate responses in bone in vitro during prolonged incubation with parathyroid hormone, prostaglandin E1, and calcitonin.

Authors:  J N Heersche; M P Heyboer; B Ng
Journal:  Endocrinology       Date:  1978-08       Impact factor: 4.736

2.  Glucocorticoid potentiation of the adenosin 3',5'-monophosphate response to parathyroid hormone in cultured rat bone cells.

Authors:  T L Chen; D Feldman
Journal:  Endocrinology       Date:  1978-02       Impact factor: 4.736

3.  Impaired renal adenylate cyclase response to parathyroid hormone in the calcium-deficient rat.

Authors:  D L Carnes; C S Anast; L R Forte
Journal:  Endocrinology       Date:  1978-01       Impact factor: 4.736

4.  Regulation of the receptor-mediated cyclic AMP response of kidney to parathyroid hormone in the vitamin D-deficient rat.

Authors:  L R Forte; D L Carnes; G A Nickols; C S Anast
Journal:  J Supramol Struct       Date:  1978

5.  Induction of metabolic changes and down regulation of bovine parathyroid hormone-responsive adenylate cyclase are dissociable in isolated osteoclastic and osteoblastic bone cells.

Authors:  G L Wong
Journal:  J Biol Chem       Date:  1979-01-10       Impact factor: 5.157

6.  Loss of calcemic effects of calcitonin and parathyroid hormone infused continuously into rats using the Alzet osmotic minipump.

Authors:  J F Obie; C W Cooper
Journal:  J Pharmacol Exp Ther       Date:  1979-06       Impact factor: 4.030

7.  Measurement of DNA in cultured human cells.

Authors:  A Leyva; W N Kelley
Journal:  Anal Biochem       Date:  1974-11       Impact factor: 3.365

8.  Enhanced sensitivity of young suckling rats to the toxic effects of 1,25-dihydroxyvitamin D3.

Authors:  L A Dostal; S U Toverud
Journal:  Calcif Tissue Int       Date:  1983-07       Impact factor: 4.333

9.  Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution.

Authors:  J F Harper; G Brooker
Journal:  J Cyclic Nucleotide Res       Date:  1975

10.  Regulation of renal adenylate cyclase by parathyroid hormone.

Authors:  D L Carnes; G A Nickols; C S Anast; L R Forte
Journal:  Am J Physiol       Date:  1980-12
View more
  3 in total

1.  Structural requirements for parathyroid hormone action in mature bone. Effects on release of cyclic adenosine monophosphate and bone gamma-carboxyglutamic acid-containing protein from perfused rat hindquarters.

Authors:  M S Calvo; M J Fryer; K J Laakso; R A Nissenson; P A Price; T M Murray; H Heath
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

2.  Interactions between calciotropic hormones.

Authors:  J N Bradbeer
Journal:  J R Soc Med       Date:  1987-08       Impact factor: 5.344

3.  The role of Zfp467 in mediating the pro-osteogenic and anti-adipogenic effects on bone and bone marrow niche.

Authors:  Phuong T Le; Hanghang Liu; Lama Alabdulaaly; Yosta Vegting; Isabella L Calle; Francesca Gori; Beate Lanske; Roland Baron; Clifford J Rosen
Journal:  Bone       Date:  2020-12-23       Impact factor: 4.398

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.